139 related articles for article (PubMed ID: 28784304)
21. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
[TBL] [Abstract][Full Text] [Related]
22. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
[TBL] [Abstract][Full Text] [Related]
23. A Pilot Trial to Quantify Plasma Exosomes in Colorectal Cancer Screening from the International Collaborative Study between Chile and Japan.
Kobayashi M; Kawachi H; Hurtado C; Wielandt AM; Ponce A; Karelovic S; Pasternak S; Delgado C; Pinto P; Carrasco H; Ito T; Okada T; Tanaka K; Odagaki T; Zárate AJ; Kronberg U; López-Köstner F; Tsubaki M; Kawano T; Eishi Y
Digestion; 2018; 98(4):270-274. PubMed ID: 30130793
[TBL] [Abstract][Full Text] [Related]
24. [Lesions Detected in Six Spanish Colorectal Cancer Screening Population Based Programmes. CRIBEA Project. Spain].
Portillo Villares I; Arana-Arri E; Idigoras Rubio I; Espinás Piñol JA; Pérez Riquelme F; de la Vega Prieto M; González Aledo A; Oceja Setien E; Vanaclocha Espi M; Ibáñez Cabanell J; Salas Trejo D;
Rev Esp Salud Publica; 2017 Feb; 91():. PubMed ID: 28218734
[TBL] [Abstract][Full Text] [Related]
25. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
[TBL] [Abstract][Full Text] [Related]
26. Faecal immunochemical test-based colorectal cancer screening programme SVIT in Slovenia: pilot phase.
Tepeš B; Stabuc B; Stefanovič M; Bračko M; Frkovič Grazio S; Novak Mlakar D; Maučec Zakotnik J
Eur J Cancer Prev; 2014 Jul; 23(4):235-9. PubMed ID: 24030444
[TBL] [Abstract][Full Text] [Related]
27. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
[TBL] [Abstract][Full Text] [Related]
28. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; de Pretis G; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex DK; Zappa M; Hassan C;
Gut; 2017 Jul; 66(7):1233-1240. PubMed ID: 26896459
[TBL] [Abstract][Full Text] [Related]
29. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test.
Fenocchi E; Martínez L; Tolve J; Montano D; Rondán M; Parra-Blanco A; Eishi Y
Eur J Cancer Prev; 2006 Oct; 15(5):384-90. PubMed ID: 16912566
[TBL] [Abstract][Full Text] [Related]
30. The colorectal cancer screening program in the local health unit n. 6 of Livorno: evaluation of the screening activity in the period 2000-2011.
Zani A; De Masi S; Maffei C; Malloggi S; Benvenuti M; Gioli V; Niccoli G; Biermann KP; Lopane P
J Prev Med Hyg; 2014 Mar; 55(1):4-9. PubMed ID: 25916025
[TBL] [Abstract][Full Text] [Related]
31. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update.
Cubiella J; Marzo-Castillejo M; Mascort-Roca JJ; Amador-Romero FJ; Bellas-Beceiro B; Clofent-Vilaplana J; Carballal S; Ferrándiz-Santos J; Gimeno-García AZ; Jover R; Mangas-Sanjuán C; Moreira L; Pellisè M; Quintero E; Rodríguez-Camacho E; Vega-Villaamil P;
Gastroenterol Hepatol; 2018 Nov; 41(9):585-596. PubMed ID: 30245076
[TBL] [Abstract][Full Text] [Related]
32. The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study.
Denis B; Sauleau EA; Gendre I; Exbrayat C; Piette C; Dancourt V; Foll Y; Ait Hadad H; Bailly L; Perrin P
Dig Liver Dis; 2014 Feb; 46(2):176-81. PubMed ID: 24054769
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of community colorectal cancer screening in 50-74 years old people in Guangzhou, 2015-2016].
Li Y; Liu HZ; Liang YR; Lin GZ; Li K; Dong H; Xu H; Wang M
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jan; 39(1):81-85. PubMed ID: 29374902
[No Abstract] [Full Text] [Related]
34. [Screening for colorectal cancer in Italy, 2010 survey].
Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M
Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271
[TBL] [Abstract][Full Text] [Related]
35. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
[TBL] [Abstract][Full Text] [Related]
36. Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: results in a northern Italian community.
Crotta S; Castiglione G; Grazzini G; Valle F; Mosconi S; Rosset R
Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):33-7. PubMed ID: 15095850
[TBL] [Abstract][Full Text] [Related]
37. Implementation of colorectal cancer screening in Spain: main results 2006-2011.
Salas Trejo D; Portillo Villares I; Espinàs Piñol JA; Ibáñez Cabanell J; Vanaclocha Espí M; Pérez Riquelme F; de la Vega Prieto M; González de Aledo Linos Á; Idígoras Rubio I; Sacristán Terroba B; López García R; Romero Hergueta C;
Eur J Cancer Prev; 2017 Jan; 26(1):17-26. PubMed ID: 27167150
[TBL] [Abstract][Full Text] [Related]
38. Contribution of the OC Sensor
Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
[TBL] [Abstract][Full Text] [Related]
39. Screening for colorectal cancer in Italy: 2005 survey.
Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
[TBL] [Abstract][Full Text] [Related]
40. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
